Biochannel assay for hybridization with biomaterial

Information

  • Patent Grant
  • 6960467
  • Patent Number
    6,960,467
  • Date Filed
    Wednesday, December 19, 2001
    23 years ago
  • Date Issued
    Tuesday, November 1, 2005
    19 years ago
Abstract
The invention relates to a microfluidic device with microchannels that have separated regions which have a member of a specific binding pair member such as DNA or RNA bound to porous polymer, beads or structures fabricated into the microchannel. The microchannels of the invention are fabricated from plastic and are operatively associated with a fluid propelling component and detector.
Description
BACKGROUND OF THE INVENTION

1. Field of the Invention


The invention pertains to the structure, fabrication of a microfluidic device and methods for conducting analysis in microfluidic devices.


2. Background of the Art Related to the Invention


Analysis utilizing specific binding pairs such as antigen/antibody; complementary DNA/DNA; DNA/RNA; RNA/RNA; biotin/avidin containing pairs are widely known in the art. Techniques for manufacturing and utilizing microfluidic devices are also well known. The art also discloses various techniques for DNA sequencing based on complementary binding of DNA.


DNA probe array technology, which utilizes binding of target single standed DNA onto immobilized DNA probes has wide applications. A large amount of research and development activities have been carried out with different technology emphasis. For example, same technologies are focused on probe placement by mechanical means. Other technologies are focused on in-situ probe synthesis that is advantageous in producing large arrays. Additionally, other technologies are focused on gel pad arrays using photopolymerizaion and piezoelectric liquid dispensing technologies.


A common challenge to all DNA hybridization technologies is the lack of control of stringency for each individual probe site. The DNA hybridization process occurs at specific temperature and salinity conditions and varies with DNA sequences. For DNA probe arrays, since the DNA probe sequences are different, hybridization recognition is never perfect under a uniform stringency condition for the entire probe array. The problem is most obvious for short duplexes which often results in single base mismatches. One can minimize the effect of mismatched hybridization by using large probe site redundancy. Stringency control has been provided for each probe site by controlling the electrophoretic movement of oligonucleotides. To successfully implement this later scheme, a meticulously engineered permeation layer is required to prevent DNA molecules or labeling agents being damaged by direct electrolysis or by the product of the electolysis.


In addition, the current DNA array technologies have failed to provide an effective solution to maximize hybridization efficiency. For diagnostic assays, the target DNA molecules are often of minute quantities. The detection limit of the assay is determined by the sensitivity of the detection device, and also by the amount of target oligos bound to the probes during the course of hybridization. In a stationary hybridization chamber where active mixing is absent, the probability of a given target molecule hybridizes to its complementary strand on the surface is determined by diffusion rate and statistics. It takes up to tens of hours for hybridization to complete at low target concentration levels. To better utilize the target molecules and enhance the hybridization, flow through technology has been proposed where the probe arrays are placed perpendicular to the fluidic flow direction. Even with flow through technology, only a portion of the target molecules can come in contact with any specific DNA probe site.


The present invention overcomes the above technical issues by sequentially placing the DNA probe sites in microfluidic channels such that the DNA probe can efficiently contact its binding partner.


U.S. Pat. No. 5,147,607 describes a variety of microassay devices which have microchannels in plastic materials with a reagent such as an antibody or DNA immobilized on the channel at different locations. Techniques for binding antibodies to the microchannel wall are described but techniques for binding DNA are not described. The binding of probes to the microchannel wall does not provide for optimum contact of probe and test sample. U.S. Pat. No. 5,843,767 describes microfabricated flowthrough porous apparatus for discrete detection of binding reactions such as DNA/DNA. WO/98/43739 describes porous flow channels having reagents immobilized in the chamber.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 shows a schematic top view of a fluid channel filled with porous gel and spotted DNA probes.



FIG. 2 shows lithographically patterned gel pads inside a microfluidic channel.



FIG. 3 shows microfluidic channels with molded plastic microstructures for DNA attachment.



FIG. 4 shows a microfluidic channel packed with beads where distinct sections of beads have a specific binding agent such as DNA.



FIG. 5 illustrates a simple initial flow being directed into numerous channels.



FIG. 6 illustrates a circulating microfluidic channel device.





SUMMARY OF THE INVENTION

The invention comprises microfluidic devices comprising a section of solid material such as a chip with a microchannel with an inlet and exit port for flowing fluids through the channels. The microchannel has separated defined regions of specific binding pair member immobilized on porous polymer, microstructures molded in the microchannels or packed beads. These structures provide for optimum contact of the immobilized binding pair member and a binding pair member in fluid flowing through the mirochannel. The porous polymer beads or microstructure must provide for flow and not obstruct the channel. The microchannel is operatively associated with a detector and a fluid propeling component to flow liquids in the channel and may also have electrodes at the exit and entrance ports.


DNA/DNA; DNA/RNA, and RNA/RNA complementary binding pair are preferred. The microchannel is operatively associated with target DNA labeled with a fluorophore, an excitation source and a detector to detect emitted fluorescence from the binding pairs. It is an object of the invention to provide a method for DNA or RNA sequencing by providing the above identified chip with DNA or RNA probes immobilized in the separated defined region to bind fluorescently labeled target DNA.


It is also an object of the present invention to provide a means determining genetic defects. The invention also provides a means for identifying pathogens through DNA analysis.


The microchannels may have a variety of configurations, feedback arms, valves, and vents to control fluid flow. There may be single or multiple channels. The invention provides for efficient contact between immobilized binding substances and binding partners in the fluid flowing through the channel. The invention provides for improved hybridization stringency control by flow modulation; shortened assay time by increasing the rate of hybridization with flow induced agitation and by bringing the target and probe into proximity within the microfluidic channel; and increased hybridization efficiency which improves sensitivity. In addition there is no interference through hydrolysis.


DETAILED DESCRIPTION OF THE INVENTION

The chips microfluidic channels of the present invention are channels generally less than 200 microns in plastic with molding or embossing technology. The channels need to be of the dimension to support pumping of the microfluidic system The microfluidic channel may have any shape, for example, it may be linear, serpentine, arc shaped and the like. The cross-sectional dimension of the channel may be square, rectagular, semicircular, etc. There may be multiple and interconnected microchannels with valves to provide for recirculation.


The section of solid material maybe chips made of glass, ceramic, metal, silicon or plastic. Chips are preferably fabricated from plastics such as expoxy resin, polyacrylic resins, polyester resins, polystyrene, polycarbonate, polyvinyl chloride and the like. Specific binding pairs are DNA/DNA or DNA/RNA complementary binding pairs.


Fluid propelling components such as pressurized gas, vacuum, electric field, magnetic field and cetrifugal force devices are operatively associated with the microchannel to move fluid through the microchannel. In addition, charged test samples may be altered by modulating the electric field against or in the direction of the flow or perpendicular to the flow. Thus, the rate of fluid flow in the microchannel can be altered to promote binding of binding pairs, for example, hybridization of DNA/DNA or DNA/RNA pairs. Also, operatively associated with the microchannel is a detector such as an optical, electrical or electrochemical detector.



FIG. 1 illustrates a serpentine shaped microfluidic channel 1 filled with porous gel 2 with discrete separate regions 3 which have attached a member of a specific binding pair, such as DNA. Sample flows into the microfluidic channel 4 and exits the channel at 5. In this approach, the channel is filled with porous gel material such as agarose or polyacrylamide. The pores of the gel are made large enough by using dilute gelling solutions to permit significant fluid flow through the gel members of specific binding pair is spotted onto the gels so that the probes are chemically attached.



FIG. 2 illustrates a microfluidic channel 10 which has patterned gel pads 11 within the channel. The gel pads are formed by photopolymerization of acrylamide using lithographic techniques.



FIG. 3 illustrates a microfluidic channel 15 where high surface area microstructures are molded into the channel. FIG. 3a shows a series of columns 16 in a distinct region and FIG. 3b shows a distinct region of doe 17 molded into channel 15 These microstructures are chemically modified and specific binding substances are attached.



FIG. 4 illustrates a microfluidic channel 20 packed alternately with regions of plain beads 21 and beads 22 having a specific binding substance, such as DNA.



FIG. 5 illustrates a microfluidic channel 25 which branches in multiple microfluidic channels 26a, b, c etc.; each of which have a distinct region of a binding substance 27 as described above. Through this embodiment, a sample can be studied in parallel to test its reactivity to the same or different specific binding substance.



FIG. 6 illustrates a chip 30 with a recirculating microfluidic channel 34. The microfluidic channel has discrete areas with specific binding substances 32 as described above and a recirculating arm 33 and a valve 34 for output after recirculation. In this embodiment the test sample is recirculated past the location of the binding partner. Thus, dilute samples or slow reacting samples can be respectively passed by the specific binding substance.


Microfabricated plastic capillary electrophoresis (CE) devices have been demonstrated in the art. Thermoplastic molded polymethylmethacrylate CE devices are described by R. M. McCormick, et al, “Microchannel electrophoretic separations of DNA in injection-molded plastic substrates,” Anal. Chem., vol. 69, pp. 2626, 1997. Eckstrom et al. investigated elastomeric polymers such as PDMS, “PCT Appl. WO91/16966, ” 1991. More recently, others have published electrophoretic separation of DNA ladders in PDMS devices, for example, C. S. Effenhauser, et al, “Integrated Capillary Electrophoresis on Flexible Silicone Microdevices,” Anal Chem., vol. 69, pp. 3451, 1997. Mastrangelo, et al describes building micro CE devices based on parylene-polycarbonate substrates using a surface micromachining approach, “An Inexpensive Plastic Technology for Microfabricated Capillary Electroophoresis Chip” presented at Micro-TAS'98, Banff, 1998.Thus, techniques are available for fabricating microchannels. The invention involves fixing specific binding substances by way of porous polymer, beads or structure in the microchannel to more efficiently promote binding.


These examples are intended to illustrate the present invention and not to limit it in spirit or scope.

Claims
  • 1. A microfluidic device comprising: (i) a first microchannel comprising a plurality of spatially distinct regions upon which a member of a specific binding pair is immobilized; (ii) at least a first entrance port and at least a first exit port for the transportation of at least one test sample; (iii) a fluid propelling component that controls that flow rate of said test sample; and (iv) a recirculating arm for recirculating said test sample across a spatially distinct regions.
  • 2. A microfluidic device according to claim 1, wherein said first microchannel is serpentine.
  • 3. A microfluidic device according to claim 1, further comprising at least one valve in said exit port.
  • 4. A microfluidic device according to claim 1, wherein said first microchannel branches into multiple second microfluidic channels each of which comprises a plurality of spatially distinct regions upon which a member of a specific binding pair is immobilized.
  • 5. A microfluidic device according to claim 1 or 4, wherein said device is fabricated from a material selected from the group consisting of silicon, silicon dioxide, glass, plastic and ceramic.
  • 6. A microfluidic device according to claim 1, where in said spatially distinct regions comprise porous polymers.
  • 7. A microfluidic device according to claim 6, wherein said porous polymer is a a hydrogel pad.
  • 8. A microfluidic device according to claim 7, wherein said hydrogel pad is a patterned gel pad further comprising spatially separated portions within said hydrogel pad.
  • 9. A microfluidic device according to claim 1, wherein each of said spatially distinct regions has a different member of a specific binding pair immobilized thereto.
  • 10. A microfluidic device according to claim 1, wherein said spatially distinct regions in said microchannel comprise beads with said member of said specific binding pair immobilized thereto.
  • 11. A microfluidic device according to claim 1, wherein said spatially distinct regions comprise microstructures fabricated into said microchannel.
  • 12. A microfluidic device according to claim 1, wherein said microstructures comprise a series of columns molded into said first microchannel.
  • 13. A microfluidic device according to claim 1, wherein said microstructures comprise domes molded into said first microchannel.
  • 14. A microfluidic device according to claim 1, wherein said specific binding pair members are nucleic acids.
  • 15. A microfluidic device according to claim 14, wherein said nucleic acid is a DNA.
  • 16. A microfluidic device according to claim 14, wherein said nucleic acid is a RNA.
  • 17. A microfluidic device according to claim 1, wherein said specific binding pair members are proteins.
  • 18. A microfluidic device according to claim 17, wherein the proteins for one member of said specific binding pair are antigens.
  • 19. A microfluidic device according to claim 17, wherein the proteins for one member of said specific binding pair are antibodies.
  • 20. A microfluidic device according to claim 1, wherein said fluid propelling component comprises a pressurized gas, a vacuum, an electrical field, a magnetic field or a centrifugal force.
  • 21. A method of detecting a specific binding member in a test sample, said method comprising passing said test sample through the microfluidic device described in claim 1, 2, or 4, to form a binding pair and detecting said binding pair.
  • 22. A method according to claim 21, wherein said test sample is recirculated.
  • 23. A method according to claim 21, wherein the flow rate of said test sample is adjusted using a fluid propelling component to increase contact between said binding pairs.
  • 24. A method according to claim 21, wherein said fluid propelling component comprises a pressurized gas, a vacuum, an electrical field, a magnetic field or a centrifugal force.
Parent Case Info

This application is, a continuation of U.S. Ser. No. 09/438,600, filed Nov. 12, 1999, now U.S. Patent No. 6,361,958, issued Mar. 26, 2002, and is hereby incorporated by reference in its entirety.

US Referenced Citations (119)
Number Name Date Kind
4415732 Caruthers et al. Nov 1983 A
4683195 Mullis et al. Jul 1987 A
4713347 Mitchell et al. Dec 1987 A
4755458 Rabbani et al. Jul 1988 A
4840893 Hill et al. Jun 1989 A
4920047 Giaever et al. Apr 1990 A
5015569 Pontius May 1991 A
5064618 Baker et al. Nov 1991 A
5066372 Weetall Nov 1991 A
5071531 Soane Dec 1991 A
5126022 Soane et al. Jun 1992 A
5130238 Malek et al. Jul 1992 A
5135627 Soane Aug 1992 A
5147607 Mochida Sep 1992 A
5192507 Taylor et al. Mar 1993 A
5296375 Kricka et al. Mar 1994 A
5304487 Wilding et al. Apr 1994 A
5455166 Walker Oct 1995 A
5486335 Wilding et al. Jan 1996 A
5494810 Barany et al. Feb 1996 A
5498392 Wilding et al. Mar 1996 A
5505321 Caron et al. Apr 1996 A
5519635 Miyake et al. May 1996 A
5552270 Khrapko et al. Sep 1996 A
5569364 Hooper et al. Oct 1996 A
5585069 Zanzucchi et al. Dec 1996 A
5587128 Wilding et al. Dec 1996 A
5591578 Meade et al. Jan 1997 A
5593838 Zanzucchi et al. Jan 1997 A
5595908 Fawcett et al. Jan 1997 A
5603351 Cherukuri et al. Feb 1997 A
5605662 Heller et al. Feb 1997 A
5620850 Bamdad et al. Apr 1997 A
5631337 Sassi et al. May 1997 A
5632876 Zanzucchi et al. May 1997 A
5632957 Heller et al. May 1997 A
5635358 Wilding et al. Jun 1997 A
5637469 Wilding et al. Jun 1997 A
5643738 Zanzucchi et al. Jul 1997 A
5653939 Hollis et al. Aug 1997 A
5681484 Zanzucchi et al. Oct 1997 A
5694932 Michel Dec 1997 A
5705346 Okamoto et al. Jan 1998 A
5705348 Meade et al. Jan 1998 A
5716825 Hancock et al. Feb 1998 A
5726026 Wilding et al. Mar 1998 A
5727548 Hill et al. Mar 1998 A
5728532 Ackley Mar 1998 A
5741462 Nova et al. Apr 1998 A
5747169 Fan et al. May 1998 A
5750015 Soane et al. May 1998 A
5755942 Zanzucchi et al. May 1998 A
5756050 Ershow et al. May 1998 A
5759866 Machida et al. Jun 1998 A
5770029 Nelson et al. Jun 1998 A
5770369 Meade et al. Jun 1998 A
5780235 Bandman et al. Jul 1998 A
5824473 Meade et al. Oct 1998 A
5837859 Teoule et al. Nov 1998 A
5843767 Beattie Dec 1998 A
5849486 Heller et al. Dec 1998 A
5863502 Southgate et al. Jan 1999 A
5866345 Wilding et al. Feb 1999 A
5942443 Parce et al. Aug 1999 A
5952172 Meade et al. Sep 1999 A
5976802 Ansorge et al. Nov 1999 A
6013170 Meade Jan 2000 A
6013459 Meade Jan 2000 A
6063573 Kayyem May 2000 A
6063589 Kellogg et al. May 2000 A
6071699 Meade et al. Jun 2000 A
6087100 Meade et al. Jul 2000 A
6090933 Kayyem et al. Jul 2000 A
6096825 Garnier Aug 2000 A
6100045 Van Es Aug 2000 A
6100099 Gordon et al. Aug 2000 A
6114122 Besemer et al. Sep 2000 A
6150119 Kopf-Sill et al. Nov 2000 A
6150180 Parce et al. Nov 2000 A
6177250 Meade et al. Jan 2001 B1
6180352 Meade et al. Jan 2001 B1
6197515 Bamdad et al. Mar 2001 B1
6197595 Anderson et al. Mar 2001 B1
6200761 Meade et al. Mar 2001 B1
6203758 Marks et al. Mar 2001 B1
6207369 Wohlstadter et al. Mar 2001 B1
6221583 Kayyem et al. Apr 2001 B1
6221677 Wu et al. Apr 2001 B1
6232062 Kayyem et al. May 2001 B1
6238870 Meade et al. May 2001 B1
6258545 Meade et al. Jul 2001 B1
6258593 Schembri et al. Jul 2001 B1
6264825 Blackburn et al. Jul 2001 B1
6265155 Meade et al. Jul 2001 B1
6268149 Meade et al. Jul 2001 B1
6268150 Meade et al. Jul 2001 B1
6277576 Meade et al. Aug 2001 B1
6290839 Kayyem et al. Sep 2001 B1
6291188 Meade et al. Sep 2001 B1
6300141 Segal et al. Oct 2001 B1
6306584 Bamdad Oct 2001 B1
6306590 Mehta et al. Oct 2001 B1
6322979 Bamdad et al. Nov 2001 B1
6326211 Anderson et al. Dec 2001 B1
6361958 Shieh et al. Mar 2002 B1
6368871 Christel et al. Apr 2002 B1
6432723 Plaxco et al. Aug 2002 B1
6472148 Bamdad et al. Oct 2002 B1
6479240 Kayyem et al. Nov 2002 B1
6495323 Kayyem et al. Dec 2002 B1
6541617 Bamdad et al. Apr 2003 B1
6572830 Burdon et al. Jun 2003 B1
6592696 Burdon et al. Jul 2003 B1
6600026 Yu Jul 2003 B1
6623945 Nair et al. Sep 2003 B1
20020006643 Kayyem et al. Jan 2002 A1
20020009810 O'Connor et al. Jan 2002 A1
20020177135 Doung et al. Nov 2002 A1
20030087228 Bamdad et al. May 2003 A1
Foreign Referenced Citations (41)
Number Date Country
0 527 905 Aug 1991 EP
0 637 998 Jul 1996 EP
0 478 319 Apr 1997 EP
0 637 996 Jul 1997 EP
0 969 083 Jan 2000 EP
1 183 102 Mar 2002 EP
WO 8605815 Oct 1986 WO
WO 9322053 Nov 1993 WO
WO 9615576 May 1996 WO
WO 8615450 Dec 1996 WO
WO 9639260 Dec 1996 WO
WO 9693252 Dec 1996 WO
WO 9716561 May 1997 WO
WO 9716835 May 1997 WO
WO 9727324 Jul 1997 WO
WO 9727329 Jul 1997 WO
WO 9731256 Aug 1997 WO
WO 9731256 Aug 1997 WO
WO 9737755 Oct 1997 WO
WO 9743629 Nov 1997 WO
WO 9804740 Feb 1998 WO
WO 9805424 Feb 1998 WO
WO 9812539 Mar 1998 WO
WO 9843739 Mar 1998 WO
WO 9813683 Apr 1998 WO
WO 9832018 Jul 1998 WO
WO 9849344 Nov 1998 WO
WO 9851823 Nov 1998 WO
WO 9929711 Jun 1999 WO
WO 9933559 Jul 1999 WO
WO 9937819 Jul 1999 WO
WO 9937819 Jul 1999 WO
WO 9967425 Dec 1999 WO
WO 9967425 Dec 1999 WO
WO 0062931 Oct 2000 WO
WO 0106016 Jan 2001 WO
WO 0106016 Jan 2001 WO
WO 0135100 May 2001 WO
WO 0154813 Aug 2001 WO
WO 0154813 Aug 2001 WO
WO 0243864 Jun 2002 WO
Related Publications (1)
Number Date Country
20020094584 A1 Jul 2002 US
Continuations (1)
Number Date Country
Parent 09438600 Nov 1999 US
Child 10028277 US